Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DIVALPROEX | 500MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2023-05-06 | 2023-05-12 | 191889 |
| APO-DOCUSATE CALCIUM | 240MG | CAPSULE | Actual shortage | 2017-08-14 | 2017-10-05 | 19120 |
| APO-DOMPERIDONE | 10MG | TABLET | Actual shortage | 2025-05-22 | 2025-05-22 | 258166 |
| APO-DOMPERIDONE | 10MG | TABLET | Resolved | 2024-05-03 | 2024-05-17 | 227076 |
| APO-DOMPERIDONE - TAB 10MG | 10MG | TABLET | Resolved | 2017-07-25 | 2017-08-08 | 16867 |
| APO-DOMPERIDONE - TAB 10MG | 10MG | TABLET | Resolved | 2018-03-13 | 2018-04-16 | 42686 |
| APO-DOMPERIDONE - TAB 10MG | 10MG | TABLET | Resolved | 2018-12-05 | 2018-12-21 | 68719 |
| APO-DOMPERIDONE - TAB 10MG | 10MG | TABLET | Resolved | 2019-01-23 | 2019-08-26 | 73311 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2024-02-23 | 2024-05-03 | 220441 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2020-08-19 | 2020-10-26 | 122477 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2018-05-01 | 2018-09-09 | 47649 |
| APO-DONEPEZIL | 5MG | TABLET | Resolved | 2024-06-06 | 2024-09-13 | 229779 |
| APO-DONEPEZIL | 5MG | TABLET | Actual shortage | 2025-11-20 | 2025-11-20 | 272347 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2021-09-17 | 2021-09-27 | 145834 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2017-05-10 | 2017-10-04 | 9928 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2025-06-26 | 2025-07-18 | 261167 |
| APO-DONEPEZIL | 10MG | TABLET | Resolved | 2022-03-04 | 2022-03-09 | 156033 |
| APO-DONEPEZIL | 5MG | TABLET | Resolved | 2017-04-04 | 2017-07-24 | 5402 |
| APO-DONEPEZIL | 10MG | TABLET | Actual shortage | 2025-08-07 | 2025-09-25 | 264543 |
| APO-DONEPEZIL | 5MG | TABLET | Resolved | 2021-05-25 | 2021-08-06 | 139834 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |